Nuwellis (NUWE) Cash from Operations Growth (1y) (2012 - 2026)
Nuwellis (NUWE) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 16.00% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 185.96% |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | 122.43% |
| 10 | Nuwellis | 118,572.00 | -1.96 Mn | 1.68 Mn | -22.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.71% |
| Dec 31, 2025 | -101.46% |
| Sep 30, 2025 | -27.36% |
| Jun 30, 2025 | 23.86% |
| Mar 31, 2025 | 11.39% |
| Dec 31, 2024 | 45.39% |
| Sep 30, 2024 | 35.40% |
| Jun 30, 2024 | 47.56% |
| Mar 31, 2024 | 53.13% |
| Dec 31, 2023 | 11.93% |
| Sep 30, 2023 | -17.44% |
| Jun 30, 2023 | -33.37% |
| Mar 31, 2023 | -26.50% |
| Dec 31, 2022 | 24.74% |
| Sep 30, 2022 | 27.40% |
| Jun 30, 2022 | -3.09% |
| Mar 31, 2022 | 10.31% |
| Dec 31, 2021 | -21.88% |
| Sep 30, 2021 | -1.89% |
| Jun 30, 2021 | -17.00% |